Found: 191
Select item for more details and to access through your institution.
Predictors of clinical response of non-small cell cancer to gefitinib.
- Published in:
- 2004
- By:
- Publication type:
- commentary
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
- Published in:
- 1997
- By:
- Publication type:
- Letter
Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 10, p. 1783, doi. 10.1007/s00432-014-1715-2
- By:
- Publication type:
- Article
Regolazione del prezzo e rimborso dei farmaci: comparatori, endpoint e ruolo della costo-efficacia.
- Published in:
- Global & Regional Health Technology Assessment, 2022, v. 9, n. 1, p. 99, doi. 10.33393/grhta.2022.2475
- By:
- Publication type:
- Article
Real-world data: come possono aiutare a migliorare la qualità dell'assistenza.
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 134, doi. 10.33393/grhta.2021.2286
- By:
- Publication type:
- Article
Early Access in Oncology: Why Is It Needed?
- Published in:
- Global & Regional Health Technology Assessment, 2019, v. 2019, p. 1, doi. 10.1177/2284240319857072
- By:
- Publication type:
- Article
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2009, v. 28, n. 9, p. 1067, doi. 10.1007/s10096-009-0748-y
- By:
- Publication type:
- Article
Narratives of change, images for change: Contemporary social documentaries in Italy.
- Published in:
- Journal of Italian Cinema & Media Studies, 2013, v. 1, n. 3, p. 311, doi. 10.1386/jicms.1.3.311_1
- By:
- Publication type:
- Article
Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 2, p. 247, doi. 10.1007/s40257-021-00645-0
- By:
- Publication type:
- Article
Predictors of Clinical Response of Non–Small Cell Cancer to Gefitinib.
- Published in:
- 2004
- By:
- Publication type:
- Letter
UNIVERSAL ENVELOPING ALGEBRAS OF PBW TYPE.
- Published in:
- Glasgow Mathematical Journal, 2012, v. 54, n. 1, p. 9, doi. 10.1017/S0017089511000310
- By:
- Publication type:
- Article
The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 8, p. e3107, doi. 10.1210/clinem/dgac359
- By:
- Publication type:
- Article
Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810292
- By:
- Publication type:
- Article
High Dose Intensity Chemotherapy without Bone Marrow Support: Role of Granulocyte-Macrophage Colony-Stimulating Factor<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1993, v. 698, n. 1, p. 389, doi. 10.1111/j.1749-6632.1993.tb17231.x
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 1, p. 219, doi. 10.1007/s10549-020-06001-w
- By:
- Publication type:
- Article
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients.
- Published in:
- Diagnostic Cytopathology, 2015, v. 43, n. 11, p. 941, doi. 10.1002/dc.23318
- By:
- Publication type:
- Article
Epidermal growth factor receptor and Kras gene expression: Reliability of mutational analysis on cytological samples.
- Published in:
- Diagnostic Cytopathology, 2013, v. 41, n. 7, p. 595, doi. 10.1002/dc.22905
- By:
- Publication type:
- Article
Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence.
- Published in:
- Clinical Oral Investigations, 2022, v. 26, n. 4, p. 3613, doi. 10.1007/s00784-021-04330-8
- By:
- Publication type:
- Article
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy.
- Published in:
- Pharmacogenomics Journal, 2014, v. 14, n. 1, p. 14, doi. 10.1038/tpj.2012.54
- By:
- Publication type:
- Article
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 19, doi. 10.3390/vaccines9010019
- By:
- Publication type:
- Article
Anti-insulin-like growth factor-I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell lines.
- Published in:
- British Journal of Pharmacology, 1997, v. 120, n. 3, p. 537, doi. 10.1038/sj.bjp.0700937
- By:
- Publication type:
- Article
Management of Malignant Pleural Effusions.
- Published in:
- Drugs, 1998, v. 55, n. 1, p. 47, doi. 10.2165/00003495-199855010-00004
- By:
- Publication type:
- Article
Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines.
- Published in:
- International Journal of Cancer, 1994, v. 56, n. 6, p. 858, doi. 10.1002/ijc.2910560618
- By:
- Publication type:
- Article
MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13073-020-00793-8
- By:
- Publication type:
- Article
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0303449
- By:
- Publication type:
- Article
AN ANTIBODY REACTIVITY-BASED ASSAY FOR DIAGNOSIS OF INVASIVE CANDIDIASIS USING PROTEIN ARRAY.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2014, v. 27, n. 3, p. 403, doi. 10.1177/039463201402700310
- By:
- Publication type:
- Article
PROTEIN MICROARRAYS ON MIDTRIMESTER AMNIOTIC FLUIDS: A NOVEL APPROACH FOR THE DIAGNOSIS OF EARLY INTRAUTERINE INFLAMMATION RELATED TO PRETERM DELIVERY.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2012, v. 25, n. 4, p. 1029, doi. 10.1177/039463201202500420
- By:
- Publication type:
- Article
Mortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-143
- By:
- Publication type:
- Article
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines.
- Published in:
- Molecular Cancer, 2012, v. 11, n. 1, p. 1, doi. 10.1186/1476-4598-11-91
- By:
- Publication type:
- Article
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 190, doi. 10.1007/s10637-021-01166-7
- By:
- Publication type:
- Article
A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 144, doi. 10.1007/s10637-017-0484-6
- By:
- Publication type:
- Article
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS‐P WT GIST.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 9, p. 636, doi. 10.1002/gcc.22753
- By:
- Publication type:
- Article
Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2021, v. 22, n. 2, p. 337, doi. 10.1007/s11154-020-09618-w
- By:
- Publication type:
- Article
Human biliary tree stem/progenitor cells immunomodulation: Role of hepatocyte growth factor.
- Published in:
- Hepatology Research, 2017, v. 47, n. 5, p. 465, doi. 10.1111/hepr.12772
- By:
- Publication type:
- Article
Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e69, doi. 10.1016/j.cllc.2021.10.009
- By:
- Publication type:
- Article
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 423, doi. 10.1016/j.cllc.2021.03.005
- By:
- Publication type:
- Article
Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Italian Multicenter Phase III Randomized Study of Cisplatin-Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Italian Multicenter Phase III Randomized Study of Cisplatin--Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 1, p. 67, doi. 10.1016/j.cllc.2014.09.001
- By:
- Publication type:
- Article
Management of Italian Patients With Advanced Non-Small-Cell Lung Cancer After Second-Line Treatment: Results of the Longitudinal Phase of the LIFE Observational Study.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 5, p. 338, doi. 10.1016/j.cllc.2014.04.004
- By:
- Publication type:
- Article
Middlebrook 7h11 Reduces Invalid Results and Turnaround Time of Phenotypic Drug-Susceptibility Testing of M. tuberculosis.
- Published in:
- International Journal of Mycobacteriology, 2022, v. 11, n. 4, p. 407, doi. 10.4103/ijmy.ijmy_159_22
- By:
- Publication type:
- Article